MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
PerkinElmer P/CF Ratio 2011-2026 | PKI
Annual P/CF Ratio PerkinElmer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 22.5 | 169 | 10.2 | 21.5 | - | 38.3 | 44.5 | 18.3 | 20.7 | - | 19.6 | 40.1 | 13.9 | 65.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 169 | 10.2 | 40.4 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M |  Germany |
 |
CareDx, Inc
CDNA
|
23.6 | $ 17.82 | - | $ 950 M |  USA |
 |
Agilent Technologies
A
|
28.3 | $ 114.84 | - | $ 34.9 B | USA |
 |
Co-Diagnostics
CODX
|
-0.201 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Charles River Laboratories International
CRL
|
10.4 | $ 168.22 | - | $ 8.34 B | USA |
 |
Castle Biosciences
CSTL
|
10.9 | $ 24.73 | - | $ 687 M | USA |
 |
Danaher Corporation
DHR
|
23.3 | $ 192.12 | - | $ 137 B | USA |
 |
DexCom
DXCM
|
17.7 | $ 63.21 | - | $ 24.7 B | USA |
 |
Fulgent Genetics
FLGT
|
22.2 | $ 16.42 | -2.38 % | $ 496 M | USA |
 |
Guardant Health
GH
|
-72.7 | $ 89.66 | - | $ 11.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M |  Britain |
 |
ICON Public Limited Company
ICLR
|
12.9 | $ 109.62 | - | $ 9.04 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
1.26 | $ 1.97 | - | $ 8.72 M | USA |
 |
Illumina
ILMN
|
19.6 | $ 127.74 | - | $ 20.3 B | USA |
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 274.46 | - | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
13.1 | $ 75.89 | - | $ 5.12 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 16.3 | - | $ 175 M |  China |
 |
Medpace Holdings
MEDP
|
18.2 | $ 496.0 | - | $ 14.3 B | USA |
 |
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | USA |
 |
Myriad Genetics
MYGN
|
227 | $ 4.67 | - | $ 432 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-0.706 | $ 4.74 | 1.07 % | $ 3.73 M | USA |
 |
NeoGenomics
NEO
|
284 | $ 8.02 | - | $ 1.03 B | USA |
 |
Neogen Corporation
NEOG
|
17.5 | $ 9.56 | - | $ 2.07 B | USA |
 |
National Research Corporation
NRC
|
11.9 | $ 17.33 | - | $ 388 M | USA |
 |
Natera
NTRA
|
-12.3 | $ 204.87 | - | $ 20.2 B | USA |
 |
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | USA |
 |
Pacific Biosciences of California
PACB
|
-4.48 | $ 1.42 | - | $ 426 M | USA |
 |
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | China |
 |
Precipio
PRPO
|
56 | $ 25.98 | 2.28 % | $ 41.7 M | USA |
 |
Personalis
PSNL
|
-5.62 | $ 6.58 | - | $ 390 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | USA |
 |
Sotera Health Company
SHC
|
16.6 | $ 14.87 | - | $ 4.22 B | USA |
 |
Soleno Therapeutics
SLNO
|
44.5 | $ 52.25 | - | $ 2.66 B | USA |
 |
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | USA |
 |
Neuronetics
STIM
|
-3.98 | $ 1.76 | - | $ 116 M | USA |
|
Biodesix
BDSX
|
-1.89 | $ 15.36 | - | $ 1.99 B | USA |
 |
Thermo Fisher Scientific
TMO
|
25.1 | $ 488.19 | - | $ 184 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
26.5 | $ 27.2 | -0.04 % | $ 20 B |  Niderland |
 |
Trinity Biotech plc
TRIB
|
9.03 | $ 0.62 | - | $ 61.9 M | Irlanda |
 |
VolitionRx Limited
VNRX
|
-1.28 | $ 0.17 | - | $ 21.4 M |  Singapore |
 |
Waters Corporation
WAT
|
30.1 | $ 304.09 | - | $ 18.1 B | USA |
 |
Exagen
XGN
|
-5.14 | $ 3.08 | - | $ 66.4 M | USA |
 |
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
-0.0144 | $ 2.59 | - | $ 84.1 K | USA |
 |
Biomerica
BMRA
|
-1.87 | $ 2.17 | - | $ 4.98 M | USA |
 |
BioNano Genomics
BNGO
|
-0.486 | $ 1.15 | - | $ 6.26 M | USA |